FDA Grants First De Novo Authorization for COVID-19 Home Use Test
Cue Health has received De Novo authorization from the FDA for its Cue COVID-19 Molecular Test, designed for both home and point-of-care use.
Read More
Search Results for: liver disease
Results of Study to Evaluate Grail’s MCED Test Announced
The analysis showed strong performance of Grail’s MCED methylation-based platform in the symptomatic population of more than 6,000 patients
Read More
New Multi-Cancer Early Detection Data Presented at ASCO 2023
The study’s multi-cancer early detection data show Exai’s RNA- and AI-based platform can detect multiple cancer types at the earliest stages using a single, standard blood sample.
Read More
Thermo Fisher Scientific Introduces Orbitrap Astral Mass Spectrometer
The new Orbitrap Astral mass spectrometer uses novel technology to deliver up to two times deeper proteome coverage and up to four times more throughput.
Read More
Labcorp Plasma Focus Liquid Biopsy Test Launches
Labcorp has launched Labcorp Plasma Focus, a new liquid biopsy test enabling targeted therapy selection for solid tumors.
Read More